Liver Cirrhoses Clinical Trial
Official title:
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study
The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
The study is investigating the effect and safety of stem cells therapy in patients with liver cirrhosis that is specifically caused by Hepatitis B infection, the participants will be chosen based on inclusive and exclusive criteria to ensure the eligibility of the patients for this study. The patients will be given therapy in the form of allogeneic mesenchymal stem cells transplantation, the stem cells in this study were provided from Prodia Stem Cell Indonesia (ProSTEM). The stem cells being will also be subjected to certain criteria to ensure the utmost safety. The data of this study will be derived from the observation results of the patients' liver damage status in weeks 4, 6 and 12. Aside from that, hemodynamic will be conducted as a part of the observation ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03219372 -
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
|
Phase 2 | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Recruiting |
NCT04057287 -
Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)
|
||
Recruiting |
NCT04089878 -
"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt
|
N/A | |
Completed |
NCT04212286 -
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
|
N/A | |
Completed |
NCT04474743 -
Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study
|
||
Recruiting |
NCT03694691 -
Developing Viability Index for Machine Perfused Livers
|
N/A | |
Terminated |
NCT04072601 -
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
|
Phase 4 | |
Terminated |
NCT03878563 -
Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC)
|
||
Terminated |
NCT04160039 -
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit
|
N/A | |
Recruiting |
NCT04191369 -
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.
|
N/A | |
Completed |
NCT03083925 -
Viatorr CX Case-control Study for Complications of Portal Hypertension
|
||
Not yet recruiting |
NCT03855709 -
Antibiotic-resistant Bacterial Infection of Hepatic Patients
|
||
Recruiting |
NCT02484573 -
Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)
|
N/A | |
Completed |
NCT03156426 -
Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis
|
||
Active, not recruiting |
NCT03868397 -
Preoperative Portal and Splanchnic Flow Measurement Using MRI
|
N/A | |
Terminated |
NCT03650660 -
Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist
|
||
Completed |
NCT03871894 -
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
|
N/A | |
Completed |
NCT03283176 -
Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin
|
||
Recruiting |
NCT03172273 -
Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites
|
N/A |